ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 2.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $64,000 | +966.7% | 8,600 | +760.0% | 0.01% | +800.0% |
| Q1 2016 | $6,000 | -90.5% | 1,000 | -90.0% | 0.00% | -90.0% |
| Q4 2015 | $63,000 | +75.0% | 10,000 | +127.3% | 0.01% | +100.0% |
| Q1 2015 | $36,000 | -91.3% | 4,400 | -92.7% | 0.01% | -91.7% |
| Q4 2014 | $412,000 | +1044.4% | 60,000 | +809.0% | 0.06% | +1100.0% |
| Q3 2014 | $36,000 | -2.7% | 6,601 | +13.8% | 0.01% | 0.0% |
| Q2 2014 | $37,000 | -38.3% | 5,801 | -22.7% | 0.01% | -37.5% |
| Q1 2014 | $60,000 | +757.1% | 7,501 | +650.1% | 0.01% | +700.0% |
| Q4 2013 | $7,000 | -97.2% | 1,000 | -92.6% | 0.00% | -97.5% |
| Q3 2013 | $249,000 | -50.8% | 13,537 | -53.3% | 0.04% | -63.3% |
| Q2 2013 | $506,000 | -33.3% | 28,957 | -31.0% | 0.11% | -23.2% |
| Q1 2013 | $759,000 | – | 41,957 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |